Escherichia coli bacteraemia: 2 years of prospective regional surveillance (2010-12)

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 1, 2014, Pages 59-66

  Horner, C ^a,b   Fawley, W ^a   Morris, K ^a   Parnell, P ^a   Denton, M ^a,b   Wilcox, M ^a,b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Antibiotic susceptibility; Epidemiology; Genetic background

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN; TRIMETHOPRIM;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLOOD CULTURE; COMMUNICABLE DISEASE; DISEASE SURVEILLANCE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GASTROINTESTINAL INFECTION; GENOTYPE; HEPATOBILIARY SYSTEM INFECTION; HOSPITAL INFECTION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; UNITED KINGDOM; URINARY TRACT INFECTION; BACTEREMIA; BACTERIUM IDENTIFICATION; CLASSIFICATION; DRUG EFFECT; EPIDEMIOLOGICAL MONITORING; EPIDEMIOLOGY; GENETIC BACKGROUND; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR TYPING;

ANTIBIOTIC SUSCEPTIBILITY; EPIDEMIOLOGY; GENETIC BACKGROUND;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENOTYPE; GREAT BRITAIN; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; PROSPECTIVE STUDIES;

EID: 84890349642     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt333     Document Type: Article

References (23)

1. Health Protection Agency. Trends in mandatory Staphylococcus aureus (MRSA and MSSA) and E. coli bacteraemia, and Clostridium difficile infection data for England up to January-March 2012. http://www.hpa. org.uk/hpr/archives/2012/hpr2412.pdf (19 April 2013, date last accessed).
2. Health Protection Agency. Voluntary surveillance of Escherichia coli bacteraemia. http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/EscherichiaColi/VoluntarySurveillance/(19 April 2013, date last accessed).
3. Health Protection Agency. Mandatory surveillance of Escherichia coli bacteraemia. http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/EscherichiaColi/MandatorySurveillance (19 April 2013, date last accessed).
4. Health Protection Agency. Quarterly Epidemiological Commentary: Mandatory MRSA, MSSA and E. coli Bacteraemia and C. difficile infection data (up to January-March 2013). London: HPA, December 2012. http://www.hpa.org.uk/webc/HPAw
5. Davies J, Abernethy JK, Guy R et al. Surveillance of Escherichia coli bacteraemia in England-preliminary results of the recently introduced mandatory surveillance scheme. Clin Microbiol Infect 2012; 18 Suppl 3: 283-4.
6. Kay I. Regional Trends. Portrait of Yorkshire and The Humber. http://www. ons.gov.uk/ons/regional-statistics/region.html?region=Yorkshire+and+ the+Humber (19 April 2013, date last accessed).
7. ColomK, Perez J, AlonsoRet al. Simpleandreliable multiplexPCRassay for detection of blaTEM, blaSHV and blaOXA-1 genes in Enterobacteriaceae. FEMS Microbiol Lett 2003; 223: 147-51.
8. WoodfordN, EllingtonMJ, CoelhoJMet al. MultiplexPCRforgenes encoding prevalentOXAcarbapenemases inAcinetobacter spp. Int JAntimicrobAgents 2006; 27: 351-3.
9. Wirth T, Falush D, Lan R et al. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 2006; 60: 1136-51.
10. Arnold C, Metherell L, Willshaw G et al. Predictive fluorescent amplifiedfragment length polymorphism analysis of Escherichia coli: high-resolution typing method with phylogenetic significance. J Clin Microbiol 1999; 37: 1274-9.
11. Gibreel TM, Dodgson AR, Cheesbrough J et al. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother 2012; 67: 346-56.
12. Melzer M, Welch C. Is Escherichia coli bacteraemia preventable?. Lancet Infect Dis 2012; 12: 103-4.
13. Underwood J, Klein JL, Newsholme W. Escherichia coli bacteraemia: how preventable is it?. J Hosp Infect 2011; 79: 364-5.
14. Davies SC. Annual Report of the Chief Medical Officer, Volume Two, 2011: Infections and the Rise of Antimicrobial Resistance. London: Department of Health, 2013.
15. Croxall G, Hale J, Weston V et al. Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings. J Antimicrob Chemother 2011; 66: 2501-8.
16. Woodford N, Ward ME, Kaufmann ME et al. Community and hospital spread of Escherichia coli producing CTX-M extendedspectrum b-lactamases in the UK. J Antimicrob Chemother 2004; 54: 735-43.
17. Xu L, Shabir S, Bodah T et al. Regional survey of CTX-M-type extendedspectrum b-lactamases among Enterobacteriaceae reveals marked heterogeneity in the distribution of the ST131 clone. J Antimicrob Chemother 2011; 66: 505-11.
18. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011; 66: 1-14.
19. EnochDA, MlangeniDA, Ekundayo J et al. Gramnegative bacteraemia- are they preventable and what will E. coli surveillance add? J Infect Prev 2013; 14: 54-9.
20. Schlackow I, Stoesser N, Walker AS et al. Increasing incidence of Escherichia coli bacteraemia is driven by an increase in antibiotic-resistant isolates: electronic database study in Oxfordshire 1999-2011. J Antimicrob Chemother 2012; 67: 1514-24.
21. Health and Social Care Information Centre. NHS Safety Thermometer. http://www.hscic.gov.uk/thermometer (19 April 2013, date last accessed).
22. de Kraker M, Wolkewitz M, Davey PG. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother 2013; 66: 398-407.
23. Health Protection Agency. Mandatory surveillance of Escherichia coli bacteraemia. Previous E. coli bacteraemia tables. June 2012. http://www. hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1317131787337 (9 July 2013, date last accessed).